Filter
1066
Filtered Results: 1066
Text search:
Jones,
S.
Featured
Recommendations
93
New Publications
152
Language
Document type
No document type
526
Studies & Reports
281
Guidelines
157
Manuals
50
Fact sheets
19
Training Material
16
Strategic & Response Plan
14
Situation Updates
2
Brochures
1
Countries / Regions
Global
56
Russia
28
Western and Central Europe
26
Latin America and the Carribbean
22
India
21
Africa
18
South Africa
18
Ukraine
17
Germany
17
Brazil
16
Kenya
14
Syria
13
Senegal
12
Sierra Leone
11
Uganda
11
Indonesia
10
Malawi
9
Eastern Europe
9
Liberia
9
Philippines
8
Asia
8
Congo, Democratic Republic of
8
Middle East and North Africa
8
Ethiopia
8
Mozambique
7
USA
7
Nepal
6
Burkina Faso
6
Zimbabwe
6
Namibia
6
Yemen
6
Chile
5
Zambia
5
Lesotho
4
Ghana
4
Cameroon
4
Nigeria
4
Guinea
4
South–East Asia Region
4
Eastern Europe and Central Asia
4
Paraguay
4
Bangladesh
4
Mali
4
South Sudan
4
Somalia
4
Myanmar / Burma
4
Colombia
3
Benin
3
China
3
Tanzania
3
West and Central Africa
3
Southern Africa
3
Sri Lanka
3
Madagascar
3
Eswatini/ Swaziland
3
Pakistan
3
Mexico
2
Turkey
2
Rwanda
2
Canada
2
Afghanistan
2
Haiti
2
Jamaica
2
United Kingdom
2
Portugal
2
East and Southern Africa
2
Argentina
2
Vietnam
2
Sudan
2
Angola
2
Botswana
2
Tajikistan
1
Thailand
1
El Salvador
1
Albania
1
Niger
1
Burundi
1
Peru
1
Cambodia
1
Guinea-Bissau
1
Venezuela
1
Jordan
1
North America
1
Uruguay
1
France
1
Spain
1
Belarus
1
Côte d’Ivoire / Ivory Coast
1
Bolivia
1
Lebanon
1
Papua New Guinea
1
Romania
1
Central African Republic
1
Chad
1
Iraq
1
Ecuador
1
Authors & Publishers
Publication Years
Category
Countries
253
Clinical Guidelines
110
Women & Child Health
76
Public Health
61
Key Resources
40
Capacity Building
11
Pharmacy & Technologies
3
Toolboxes
Mental Health
186
COVID-19
117
Planetary Health
80
HIV
60
TB
43
Disability
43
Caregiver
35
NCDs
35
NTDs
31
Ebola
25
AMR
24
Refugee
20
Conflict
20
Health Financing Toolbox
19
Rapid Response
17
Natural Hazards
13
Social Ethics
13
Global Health Education
12
Pharmacy
9
Zika
9
Specific Hazards
7
Polio
4
Health Financing
2
Lymphatic filariasis is a neglected tropical disease that can cause permanent disability through disruption of the lymphatic system. This disease is caused by parasitic filarial worms that are transmitted by mosquitos. Mass drug administration (MDA) of antihelmintics is recommended by WHO to elimina...
La promotion de la santé et la prévention des maladies nécessitent une action multisectorielle qui renforce les environnements favorables à la santé et oriente les comportements. Au niveau des cantons et des communes, de nombreuses politiques, telles
la protection de la jeunesse, la promotion ...
Trachoma is the leading infectious cause of blindness (2). It is characterized by repeated
conjunctival infection with particular strains of Chlamydia trachomatis. This scars the conjunctivae and,
in some cases, leads to trichiasis with or without entropion. The abrasive action of eyelashes can
d...
The Indigenous tribe called the Wiwa lives retracted in the Sierra Nevada de Santa Marta, Colombia. Little is known about their health status and whether the health care system in place covers their needs.
Abstract: Chagas disease is caused by infection with the protozoan Trypanosoma cruzi, and although over 100 years have passed since the discovery of Chagas disease, it still presents an increasing problem for global public health. A plethora of information concerning the chronic phase of human Chaga...
Pharmaceutical News
Evaluation of Saccharide Content of the WHO 2nd International Standard for Haemophilus Influenzae Polysaccharide Polyribosyl Ribitol Phosphate (PRP) by HPAECPAD Analysis Following Acid Hydrolysis
Consultation Documents
Lamivudine and tenofovir disoproxil fumarate tablets (lami...
Trypanosoma cruzi is the etiological agent of Chagas disease (CD), considered one of the most important parasitic infections in Latin America. Between 25 and 90 million humans are at infection risk via at least one of multiple infection mechanisms. Under natural conditions, the principal transmissio...
Arsenical monotherapies were previously very successful for treating human African trypanosomiasis (HAT).
Melarsoprol resistance emerged as early as the 1970s and was widespread by the late 1990s.
Melarsoprol resistance represents the only example of widespread drug resistance in HAT patients wher...
Mali national action plan on antimicrobial resistance: review of progress in the human health sector
This policy brief aims to provide a review of the current progress on implementing the Mali national action plan on AMR, identifies critical gaps, and highlights findings to accelerate further progress in the human health sector. The target audience includes all those concerned with implementing act...
Mycetoma is a specific chronic, granulomatous, inflammatory disease. It usually involves the subcutaneous tissue, most probably after traumatic inoculation of the causative organism. It has a prolonged, progressive, and indolent course, and, if untreated, it ultimately leads to destruction of the de...
Mycetoma is a chronic infectious disease of the subcutaneous tissue with a high morbidity. This disease has been reported from countries between 30°N and 15°S since 1840 but the exact burden of disease is not known. It is currently unknown what the incidence, prevalence and the number of reported ...
Snakebite envenoming is a serious public health problem in Central America, where approximately 5,500 cases occur every year. Panama has the highest incidence and El Salvador the lowest. The majority, and most severe, cases are inflicted by the pit viper Bothrops asper (family Viperidae), locally kn...
L'anthrax est une maladie bactérienne, causée par Bacillus anthracis, qui peut se transmettre des animaux
herbivores à l'homme par contact étroit, en mangeant de la viande d'animaux infectés, ou par contamination
environnementale. L'anthrax peut être une maladie grave nécessitant un diagnos...
The Fifty-first World Health Assembly adopted resolution WHA51.11 in 1998, which targets the
global elimination of trachoma as a public health problem by 2020 (1). The strategy recommended
to achieve that goal is encapsulated by the acronym “SAFE”, which represents: Surgery for
individuals wi...
En 1998, la Cinquante-et-Unième Assemblée mondiale de la Santé a adopté la résolution
WHA51.11 qui vise l’élimination mondiale du trachome en tant que problème de santé publique
à l’horizon 2020 (1). La stratégie recommandée pour atteindre cet objectif est récapitulée dans
le sig...
La quincuagésima primera Asamblea de la Salud Mundial aprobó la resolución WHA51.11 en
1998, que busca la eliminación mundial del tracoma como problema de salud pública para el 2020
(1). La estrategia recomendada para lograr ese objetivo está encapsulada por las siglas "SAFE", que
represent...
The report summarizes the estimates of the burden of disease attributable to unsafe drinking water, sanitation, and hygiene for the year 2019 for four health outcomes - diarrhoea, acute respiratory infections, soil-transmitted helminthiases, and undernutrition - which are included in the reporting o...
Since 2002 the distribution of external funding to reproductive, maternal, newborn, and child health (RMNCH) has become more equitable and better targeted at the poorest countries and those experiencing the highest mortality. The aid envelope is not large enough or well enough concentrated to close ...
Strengthening resource tracking and monitorig health expanditure
Ebola disease and Marburg disease outbreaks continue to occur in Africa, with increased frequency. In addition to resulting in high mortality and morbidity, the outbreaks generate fear and mistrust about the response activities within the communities affected.
Infection prevention and control (IP...
